地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18327026838
传真:18327026838
邮箱:sales@amyjet.com

艾美捷科技代理Nordmark Biochemicals酶制剂。
SERVA Electrophoresis GmbH专业生产生化试剂,两性电解质、等电聚焦蛋白 Marker 等电泳试剂,IEF 预制胶、上样梳等电泳耗材,高性能等电聚焦电泳系统设备等产品。SERVA Electrophoresis GmbH总部位于德国海德堡。该公司在生命科学领域,特别是蛋白质研究、分子生物学和生物化学方面,提供高质量的电泳设备和试剂。
Nordmark Biochemicals 是 Nordmark Pharma GmbH 的一个业务部门,专注于生物化学领域的产品开发和生产。该部门主要提供用于制药、生物技术和研究领域的高纯度酶和生化试剂。Nordmark Biochemicals提供多种通用型胶原酶、温和型胶原酶、GMP 级胶原酶和中性蛋白酶等,适用于多种细胞,如:胰岛、脂肪细胞、肝细胞、心肌细胞、干细胞、树突细胞、肿瘤细胞等。应用领域:Nordmark Biochemicals 的生产设施符合国际质量标准,如 GMP(良好生产规范)和 ISO 认证,确保产品的高质量和一致性。
<<<< " data-original="http://gbiosciences.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Nordmark Biochemicals酶制剂"> 艾美捷科技代理Nordmark Biochemicals酶制剂

RayBiotech is a leading life sciences company providing proteomic discovery tools. RayBiotech has nearly 150 employees whose objectives are to provide excellent products and service worldwide to RayBiotech customers which include scientists in industry, academic and research institutes in 41 countries. RayBiotech is committed to accelerating customer success through innovation and leadership in the Life Sciences.
RayBiotech公司致力于开发、研制、生产及销售以抗体芯片、ELISA/EIA、抗原抗体为主的酶免产品,不仅拥有强大的技术团队,其中40%博士及博士后学历,而且十分重视产品的科技创新,公司先后与哈佛大学、普林斯顿大学等国际多家权威科研机构、院校紧密合作,将技术进行广泛应用。世界各国众多科学家使用了RayBiotech的抗体芯片等酶免产品已发表数千篇文献在Nature、Nature Medicine、Cell、PNAS、Lancet 等世界顶级期刊上。客户对RayBiotech芯片技术和产品的质量都给予了肯定和很高的评价。以抗体芯片生产为核心,RayBiotech公司将生产线扩大到ELISA/EIA、抗原抗体等数万种产品,涵盖了免疫学领域大多数主要产品种类。经过10余年的发展和品牌积累,RayBiotech已成为国际上公认的蛋白芯片的先驱企业,抗体及酶免产品专家。
RayBiotech公司的主要产品包括:
(1)Arrays
Antibody Arrays
Glycobiology Arrays
Protein Arrays
Phosphorylation Arrays
(2)ELISA Kits
Sandwich ELISA Kits
EIA Kits
Transcription Factor Activity Assay Kits
Phosphorylation ELISA Kits
Post-Translational Modification ELISA Kits
Cell-Based Phosphorylation ELISA Kits
SpeedELISA Kits
IQELISA Kits
(3)Functional Assays
Cell Viability Assays
Lipid Transfer Assays
Luciferase Assays
Molecular Biology Assays
Oxidative Stress Assays
Phosphorylation Assays
Apoptosis Assays
Cytotoxicity Assays
Metabolism Assays
(4)Reagents
Antibodies
Proteins
Supplemental Reagents
(5)Flow Cytometry
Flow Cytometry Antibodies
Live/Dead Markers
Intracellular Staining Kits
(6)Other Products
Lab Equipment
Isotyping
Software
Cell Fractionation Kits
Protein Quantification
Magnetic Beads
Blood Collection
Kit Components
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://gbiosciences.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="RayBiotech"> RayBiotech
艾美捷科技代理SeraCare对照及参比物质。
艾美捷科技有限公司,自2018年与SeraCare(现隶属于LGC Clinical Diagnostics)合作以来,长期为中国客户提供包括SeraSeq系列参比物质,领域包括肿瘤、生殖健康和遗传病。SeraCare研发和生产一系列临床参比物质,可以用于任何研发阶段,以确保临床基因组学检测结果的准确性。
SeraCare参比物质涵盖的范围:
1)Next Generation Sequencing
2)Sanger Sequencing
3)Real-time PCR and digital PCR (dPCR)
4)Microarray
主要特点
1)Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs, and RNA fusions
2)Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs
3)Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA in plasma, and FFPE
4)Manufactured in cGMP-compliant, ISO 13485-certified facilities
5)Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers
| 参比物质 | 货号 | 规格 |
| Seraseq® Whole Transcriptome RNA Seq Mix | 0710-2129 | 1 x 20 µl |
| Seraseq® Unmethylated ctDNA Mutation Mix | 0710-3088 | 1 x 25 µl |
| Seraseq® Tumor Mutation DNA Mix v2 AF 7 HC | 0710-0095 | 1 x 25 µl |
| Seraseq® Tumor Mutation DNA Mix v2 AF 10 HC | 0710-0094 | 1 x 25 µl |
| Seraseq® Tri-Level Tumor Mutation DNA Mix v2 HC | 0710-0097 | 1 x 25 µl |
| Seraseq® TNA (DNA/RNA) WT Mix | 0710-1580 | 2 x 20 µl |
| Seraseq® Solid Tumor CNV Mix, +6 copies | 0710-2867 | 1 x 20 µl |
| Seraseq® Solid Tumor CNV Mix, +3 copies | 0710-2866 | 1 x 20 µl |
| Seraseq® Solid Tumor CNV Mix, +12 copies | 0710-2868 | 1 x 20 µl |
| Seraseq® NTRK Fusion RNA Mix | 0710-1696 | 1 x 20 µl |
| Seraseq® Myeloid Mutation DNA Mix | 0710-0408 | 1 x 25 µl |
| Seraseq® Myeloid Fusion RNA Mix | 0710-0407 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix WT | 0710-2646 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix AF1% | 0710-2649 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix AF0.5% | 0710-2648 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix AF0.1% | 0710-2647 | 1 x 25 µl |
| Seraseq® MSI Reference Panel Mix AF5% | 0710-1675 | 2 x 15 µl |
| Seraseq® MSI Reference Panel Mix AF20% | 0710-1676 | 2 x 15 µl |
| Seraseq® Methylated ctDNA Mutation Mix | 0710-3089 | 1 x 25 µl |
| Seraseq® Lymphoma DNA Mutation Mix | 0710-2203 | 1 x 25 µl |
| Seraseq™ Lung & Brain CNV Mix, + 6 copies | 0710-0415 | 1 x 20 µl |
| Seraseq® Lung & Brain CNV Mix, + 3 copies | 0710-0414 | 1 x 20 µl |
| Seraseq® Lung & Brain CNV Mix, + 12 copies | 0710-0416 | 1 x 20 µl |
| Seraseq® HRD gDNA Negative Mix | 0710-2881 | 2 x 20 µl |
| Seraseq® HRD gDNA Low-Positive Mix | 0710-2880 | 2 x 20 µl |
| Seraseq® HRD gDNA High-Positive Mix | 0710-2879 | 2 x 20 µl |
| Seraseq® gDNA TMB Reference Panel Mix | 0710-2463 | 5 x 20 µl |
| Seraseq® gDNA TMB Mix Score 9 | 0710-1325 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 7 | 0710-1326 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 26 | 0710-1323 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 20 | 0710-1324 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 13 | 0710-1586 | 2 x 10 µl |
| Seraseq® gDNA MSI-High Mix | 0710-1670 | 1 x 20 µl |
| Seraseq® gDNA BRCA1/2 LGR Somatic Mutation Mix | 0730-0567 | 1 x 25 µl |
| Seraseq® gDNA BRCA1/2 LGR Inherited Mutation Mix | 0730-0568 | 1 x 25 µl |
| Seraseq® Fusion RNA Mix v4 | 0710-0497 | 1 x 25 µl |
| Seraseq® FFPE WT (DNA/RNA) Reference Material | 0710-0137 | 1 x 10 µm |
| Seraseq® FFPE TMB RM Score 9 | 0710-1308 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 7 | 0710-1310 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 26 | 0710-1307 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 20 | 0710-1309 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 13 | 0710-1618 | 2 x 10 um |
| Seraseq® FFPE Solid Tumor CNV Reference Materials | 0710-2865 | 1 x 10 µm |
| Seraseq® FFPE NTRK Fusion RNA Reference Material | 0710-1031 | 1 x 10 µm |
| Seraseq® FFPE MSI-High RM | 0710-2236 | 1 x 10 um |
| Seraseq® FFPE Lymphoma DNA Reference Material | 0710-2202 | 1 x 10 µm |
| Seraseq® FFPE HRD Negative RM | 0710-2644 | 1 x 10 µm |
| Seraseq® FFPE HRD Low-Positive RM | 0710-2645 | 1 x 10 µm |
| Seraseq® FFPE HRD High-Positive RM | 0710-2643 | 1 x 10 µm |
| Seraseq® FFPE Tumor Fusion RNA v4 Reference Material | 0710-0496 | 1 x 10 µm |
| Seraseq® FFPE BRCA1/2 LGR Reference Material | 0730-0564 | 1 x 10 µm |
| Seraseq® ctDNA Reference Material v2 WT | 0710-0208 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF2% | 0710-0203 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF1% | 0710-0204 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF0.5% | 0710-0205 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF0.125% | 0710-0207 | 1 x 5 mL |
| Seraseq® ctDNA Mutation Mix v2 WT | 0710-0144 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF2% | 0710-0139 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF1% | 0710-0140 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF0.5% | 0710-0141 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF0.25% | 0710-0142 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF0.125% | 0710-0143 | 1 x 25 µl |
| Seraseq® ctDNA MRD Panel Mix | 0710-2146 | 4 x 20 µl |
| Seraseq® ctDNA Complete™ Reference Material WT (0%) | 0710-0674 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF5% | 0710-0669 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF2.5% | 0710-0670 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF1% | 0710-0671 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF0.5% | 0710-0672 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF0.1% | 0710-0673 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Mutation Mix WT (0%) | 0710-0533 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF5% | 0710-0528 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF2.5% | 0710-0529 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF1% | 0710-0530 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF0.5% | 0710-0531 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF0.1% | 0710-0532 | 1 x 25 µl |
| Seraseq® Compromised FFPE WT (DNA/RNA) RM | 0710-1710 | 1 x 10 µm |
| Seraseq® Compromised FFPE Tumor DNA RM | 0710-1492 | 1 x 10 µm |
| Seraseq® Breast CNV Mix, + 6 copies | 0710-0412 | 1 x 20 µl |
| Seraseq® Breast CNV Mix, + 3 copies | 0710-0411 | 1 x 20 µl |
| Seraseq® Breast CNV Mix, + 12 copies | 0710-0413 | 1 x 20 µl |
| Seraseq® Blood TMB Mix Score 7 | 0710-2087 | 3 x 20 µl |
| Seraseq® Blood TMB Mix Score 26 | 0710-2090 | 3 x 20 µl |
| Seraseq® Blood TMB Mix Score 20 | 0710-2089 | 3 x 20 µl |
| Seraseq® Blood TMB Mix Score 13 | 0710-2088 | 3 x 20 µl |
| Seraseq® Turner Syndrome (XO) Reference Material | 0720-0952 | 1 x 1 mL |
| Seraseq® Trisomy 21 Male-Matched Reference Material | 0720-0167 | 1 x 1 mL |
| Seraseq® Trisomy 21 Female-Matched Reference Material | 0720-0168 | 1 x 1 mL |
| Seraseq® Trisomy 18 Male-Matched Reference Material | 0720-0171 | 1 x 1 mL |
| Seraseq® Trisomy 18 Female-Matched Reference Material | 0720-0172 | 1 x 1 mL |
| Seraseq® Trisomy 13 Male-Matched Reference Material | 0720-0779 | 1 x 1 mL |
| Seraseq® Trisomy 13 Female-Matched Reference Material | 0720-0780 | 1 x 1 mL |
| Seraseq® Triple X Syndrome (XXX) Reference Material | 0720-1069 | 1 x 1 mL |
| Seraseq® PGT-A Trisomy 21 Reference Material | 0720-0775 | 1 x 10 µl |
| Seraseq® PGT-A Trisomy 18 Reference Material | 0720-0776 | 1 x 10 µl |
| Seraseq® PGT-A Trisomy 13 Reference Material | 0720-0777 | 1 x 10 µl |
| Seraseq® PGT-A Euploid Reference Material | 0720-0778 | 1 x 10 µl |
| Seraseq® Klinefelter Syndrome (XXY) Reference Material | 0720-0953 | 1 x 1 mL |
| Seraseq® Jacobs Syndrome (XYY) Reference Material | 0720-0954 | 1 x 1 mL |
| Seraseq® Euploid Male-Matched Reference Material | 0720-0169 | 1 x 1 mL |
| Seraseq® Euploid Female-Matched Reference Material | 0720-0170 | 1 x 1 mL |
| Seraseq® 22q11 Male-Matched Reference Material | 0720-0173 | 1 x 1 mL |
| Seraseq® 22q11 Female-Matched Reference Material | 0720-0174 | 1 x 1 mL |
| Seraseq® Inherited Cancer DNA Mix v1 | 0730-0003 | 1 x 200 µL |
| Seraseq® gDNA BRCA1/2 LGR Inherited Mutation Mix | 0730-0568 | 1 x 25 µL |
| Seraseq® FFPE BRCA1/2 LGR Reference Material | 0730-0564 | 1 x 10 µm |
| Seraseq® Cardiomyopathy Reference Material | 0740-0021 | 1 x 200 µL |

PROGEN公司主要产品线:体外诊断领域中细胞生物学和生物医院学实验所需要的科研试剂盒抗体。核心产品主要为:K19抗体的衍生类产品和细胞胶蛋白类抗体等。
PROGEN is a specialist for premium immunochemicals since 1983. The company develops and manufactures test kits and reagents marketed as PROGEN products and is expanding its product portfolio on a continuous basis. The German Stifterverband has recognized PROGEN's research activities with the "Innovative through Research" award (2018).
Progen Biotech的主要产品包括:
(1)Antibodies
Adeno-Associated Virus (AAV) & M13
Cell cycle & apoptosis
Endocrinology
Immunology
Cytoskeleton & nuclear antigens
Cytoskeleton
Extracellular Matrix Proteins
Cell Membrane & Metabolism
Nuclear Antigens
Cytokeratins & hair keratins
Basic type II cytokeratin/ keratin K1-8
Acidic type I cytokeratin/ keratin K9-20
Cytokeratin/ keratin pan
Acidic type I hair keratin
Basic type II hair keratin
Inner root sheet keratin (irs)
Type I & II hair keratin pan
Lipid Metabolism
Microbiology
Nephrology
Neurobiology
Sperm Cell Proteins
Tumor biology
Adhesion, Junction & Desmosome Proteins
Secondary Antibodies
(2)Diagnostic Assays
Infectious Disease
Coagulation
Lipid Metabolism
(3)Phage Display
(4)AAV
(5)Antigens and Controls
(6)Density Gradient Media
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Epredia品牌。
Epredia是一家全球性公司,致力于实现精准癌症诊断,Epredia的产品组合代表了整个组织学工作流程,从标本采集到处理,从切片到染色,从成像到存档。Epredia由Shandon、Microm、Menzel Gläser和Richard-Allan Scientific等品牌组成,拥有广泛的解决方案,这些解决方案已经并将继续改变解剖病理学市场。
Epredia的解决方案包括:
(1)组织处理和包埋解决方案:随着新的工作环境和人员配备挑战的出现,了解组织处理试剂如何节省时间并提高处理组织的质量至关重要。
(2)标签和跟踪解决方案:PrintMate AS™盒式打印机和SlideMate幻灯片打印机系列,减少因标签错误而出错的机会,并通过自动化的方式标记和跟踪实验室样本和幻灯片来简化工作流程。
(3)组合解决方案:Epredia一直在寻找简化工作流程的方法,同时增强结果。
(4)存档解决方案:存档是实验室中确保整个组织学工作流程中样本安全的重要过程。
< " data-original="http://gbiosciences.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Epredia品牌"> 艾美捷科技代理Epredia品牌
艾美捷科技代理Nebulabio全系列药合成、递送及点击化学产品。
北京辰辉创聚生物技术有限公司(Nebula Biotechnology Co., Ltd.)是一家专注于创新药物研发关键试剂研发的高科技企业。自2022年成立以来,已推出药物标准品系列产品、抗体药参比试剂系列产品、活性小分子系列产品。公司已和全球近50家制药公司、药物研发机构、诊断试剂产品公司建立了友好的业务合作关系。
产品列表如下,欢迎咨询。
| 产品名称 | 货号 | 规格 | CAS号 |
| trans-Cyclooct-4-en-L-Lysine (EQUATORIAL) | NBS-230715 | 500mg; 1g | 1380349-88-1 |
| PrDiAzK | NBS-230716 | 100mg; 1g | 2231405-64-2 |
| exo-BCN-Fmoc-L-Lysine (BCN) | NBS-230717 | 500mg; 1g | 1493802-76-8 |
| DiAzK | NBS-230718 | 100mg; 1g | 1253643-88-7 |
| N3-Lys | NBS-230719 | 1g; 5g | 1167421-25-1 |
| cyclopropene-L-Lysine (CP) | NBS-230720 | 500mg; 1g | 1610703-09-7 |
| endo-BCN-Fmoc-L-Lysine (BCN) | NBS-230721 | 500mg; 1g | 1493802-95-1 |
| trans-Cyclooct-2-en-L-Lysine (TCO*A) | NBS-230722 | 500mg; 1g | 1801936-26-4 |
| exo BCN-L-Lysine | NBS-230723 | 500mg; 1g | 1384100-45-1 |
| Norbonene-CH2-L-Lysine (NBO) | NBS-230724 | 500mg | 1378916-76-7 (H+) |
| rac BCN-L-Lysine | NBS-230725 | 500mg; 1g; 5g | N/A |
| trans-Cyclooct-4-en-L-Lysine (AXIAL) | NBS-230726 | 500mg; 1g | 1380349-88-1 |
| endo BCN-L-Lysine | NBS-230727 | 500mg; 1g | 1493802-96-2 / 1580501-90-1 |
| PrK -HCl-salt | NBS-230728 | 1g; 5g | 1215204-46-8 (H+) // 1428330-91-9 (HCl) |
| SCO-L-Lysine-HCO2H-salt (purity 99%) | NBS-230729 | 10mg | 1309581-49-4 |
| SCO-L-Lysine-HCO2H-salt (purity 95%) | NBS-230730 | 500mg; 1g; 5g | 1309581-49-4 |
| TCO*A-OH (AXIAL) | NBS-230731 | 100mg; 1g | 1414375-00-0 |
| Me-Tet-PEG2-NH2 | NBS-230732 | 100mg; 500mg | N/A |
| Coumarin-PEG4-Tetrazine | NBS-230734 | 1mg; 5mg | N/A |
| Coumarin-C2-exoBCN | NBS-230735 | 1mg; 5mg | 2488174-17-8 |
| Coumarin-C2-TCO (axial) | NBS-230736 | 1mg; 5mg | 2488174-16-7 |
| (E)-cyclooctene doxorubicin conjugate (axial) | NBS-230738 | 10mg | 1438387-95-1 |
| SCO-NHS carbonate | NBS-230739 | 100mg; 1g | N/A |
| exo-BCN-NHS carbonate | NBS-230740 | 500mg; 1g | 1493802-77-9 |
| endo-BCN-NHS carbonate | NBS-230741 | 500mg; 1g | 1426827-79-3 |
| TCO4-NHS carbonate (EQUATORIAL) | NBS-230742 | 500mg; 1g | 1191901-33-3 |
| TCO4-NHS carbonate (AXIAL) | NBS-230743 | 500mg; 1g | 1191901-33-3 |
| TCO*-NHS carbonate (EQUATORIAL) | NBS-230744 | 500mg; 1g | 1610931-22-0 |
| TCO*-NHS carbonate (AXIAL) | NBS-230745 | 100mg; 1g | 1610931-22-0 |
| Tetrazine-Amine-TFA-salt | NBS-230746 | 100mg; 500mg | 1092689-33-2 |
| TCO*E-active ester (p-NPC, equatorial) | NBS-230747 | 100mg; 1g | 1580501-97-8 |
| exo BCN-OH | NBS-230850 | 500mg; 1g | 1263291-41-3 |
| SCO-active ester (p-NPE) | NBS-230851 | 500mg; 1g | 1309581-51-8 |
| SCO-OH | NBS-230852 | 500mg; 1g | 29916-92-5 |
| endo BCN-OH | NBS-230853 | 500mg; 1g | 1263166-90-0 |
| Aminopentyl-Tetrazine-HCl-salt | NBS-230854 | 100mg; 500mg | N/A |
| (E)-cyclooctene doxorubicin conjugate (EQUATORIAL) | NBS-230855 | 10mg | 1438387-96-2 |
| (E)-cyclooct-4-enol / equatorial-TCO / E | NBS-230856 | 100mg; 1g | 39637-79-1 |
| (E)-cyclooct-4-en active ester / TCO/E- active ester (p-NPE) (EQUATORIAL) | NBS-230857 | 100mg; 1g | 1354323-64-0 |
| (E)-cyclooct-4-en active ester / TCO4 / A- active ester (p-NPE) (AXIAL) | NBS-230858 | 100mg; 1g | 1438415-89-4 |
| (E)-cyclooct-4-enol / axial -TCO4 / A | NBS-230859 | 100mg; 1g | 39637-78-0 |
| Tetrazine active ester (Tetrazine-NHS) | NBS-230860 | 100mg; 500mg | 1384271-41-3 |
| Aminopropyl-Tetrazine-HCl-salt | NBS-230861 | 100mg; 500mg | 1146968-37-7 (H+) |
| N-Trifluoro-Acetylpropargylamine | NBS-230862 | 1g; 5g | 14719-21-2 |
| Methyl-Tetrazine-Amine- HCO2H-salt | NBS-230863 | 100mg; 500mg | 1345955-28-3 (H) |
| Tetrazine-Amine-HCO2H-salt | NBS-230864 | 100mg; 500mg | 1092689-33-2 (H) |
| TCO*A-OH (EQUATORIAL) | NBS-230865 | 100mg; 1g | 93301-75-8 |
| BCN-3,5-diene-9-methanol | NBS-230866 | 500mg; 1g | 1072439-47-4 |
| TCO*A-active ester (p-NPE) | NBS-230867 | 100mg; 1g | 1580501-97-8 |
| exo BCN-active ester (p-NPE) | NBS-230868 | 500mg | 1380006-72-3 |
| endo BCN-active ester (p-NPE) | NBS-230869 | 500mg; 1g | 1263166-91-1 |
| 12-Azidododecanoic acid | NBS-230876 | 100mg | 80667-36-3 |
| EdU | NBS-230877 | 100mg | 61135-33-9 |
| Pr-DiAz-OH | NBS-230878 | 100mg; 500mg | 1450754-41-2 |
| Pr-DiAz-NHSC | NBS-230879 | 100mg; 500mg | 2488239-96-7 |
| DiAz-NHSE | NBS-230880 | 100mg; 500mg | 1239017-80-1 |
| Pr-DiAz-NHSE | NBS-230881 | 100mg; 500mg | 2012552-32-6 |
| Pr-DiAz-COOH | NBS-230882 | 100mg; 500mg | 1450754-37-6 |
| Pr-DiAz-NH2 | NBS-230883 | 100mg; 500mg | 1450752-97-2 |
| Coumarin-PEG8-Tetrazine | NBS-230884 | 1mg; 5mg | N/A |
| Coumarin-PEG3-TCO* (AXIAL) | NBS-230885 | 1mg; 5mg | 2488319-02-2 |
| Coumarin-PEG7-TCO* (AXIAL) | NBS-230886 | 1mg; 5mg | N/A |
| Coumarin-PEG2-TCO* (AXIAL) | NBS-230891 | 1mg; 5mg | 2488174-19-0 |
| Coumarin-PEG2-exoBCN | NBS-230892 | 1mg; 5mg | 2488174-18-9 |
| Coumarin-PEG2-SCO | NBS-230893 | 1mg; 5mg | 2488239-94-5 |
| Coumarin-PEG2-endoBCN | NBS-230894 | 1mg; 5mg | 2488174-18-9 |
| Biotin-PEG3-CoenzymeA | NBS-230895 | 100µg; 1mg | N/A |
| Bis-Cyano-PEG9 | NBS-230896 | 100mg; 500mg | 41263-81-4 |
| Bis-Cyano-PEG5 | NBS-230897 | 100mg; 500mg | 41263-79-0 |
| Bis-Cyano-PEG4 | NBS-230898 | 100mg; 500mg | 57741-46-5 |
| N3-PEG8-t-butyl ester | NBS-230899 | 100mg; 1g | 1623791-99-0 |
| N3-PEG5-t-butyl ester | NBS-230900 | 100mg; 1g | 1415800-41-7 |
| N3-PEG4-t-butyl ester | NBS-230901 | 100mg; 1g | 581066-04-8 |
| N3-PEG3-t-butyl ester | NBS-230902 | 100mg; 1g | 252881-73-5 |
| Boc-N-Amido-PEG7-N3 | NBS-230903 | 100mg; 500mg | 206265-96-5 |
| Boc-N-Amido-PEG3-N3 | NBS-230904 | 100mg; 500mg | 642091-68-7 |
| Boc-N-Amido-PEG2-N3 | NBS-230905 | 100mg; 500mg | 950683-55-3 |
| Boc-N-Amido-PEG4-Alkyne | NBS-230906 | 100mg; 500mg | 1219810-90-8 |
| Boc-N-Amido-PEG3-Alkyne | NBS-230907 | 100mg; 500mg | 1333880-60-6 |
| Fluorescent-PEG8-Me-Tet | NBS-230908 | 5mg; 25mg | N/A |
| Fluorescent-PEG4-Me-Tet | NBS-230909 | 5mg; 25mg | N/A |
| Fluorescent-PEG3-Me-Tet | NBS-230910 | 5mg; 25mg | N/A |
| TAMRA-PEG8-Alkyne | NBS-230911 | 5mg; 25mg | N/A |
| TAMRA-PEG4-Alkyne | NBS-230912 | 5mg; 25mg | 1225057-68-0 |
| TAMRA-PEG3-Alkyne | NBS-230913 | 5mg; 25mg | N/A |
| TAMRA-PEG7-N3 | NBS-230914 | 5mg; 25mg | N/A |
| TAMRA-PEG3-N3 | NBS-230915 | 5mg; 25mg | 1228100-59-1 |
| TAMRA-PEG2-N3 | NBS-230916 | 5mg; 25mg | N/A |
| TAMRA-PEG8-COOH | NBS-230917 | 5mg; 25mg | N/A |
| TAMRA-PEG4-COOH | NBS-230918 | 5mg; 25mg | N/A |
| TAMRA-PEG3-COOH | NBS-230919 | 5mg; 25mg | N/A |
| TAMRA-PEG8-NHS | NBS-230920 | 5mg; 25mg | 2067281-44-9 |
| TAMRA-PEG4-NHS | NBS-230921 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NHS | NBS-230922 | 5mg; 25mg | N/A |
| TAMRA-PEG7-Maleimide | NBS-230923 | 5mg; 25mg | N/A |
| TAMRA-PEG3-Maleimide | NBS-230924 | 5mg; 25mg | N/A |
| TAMRA-PEG2-Maleimide | NBS-230925 | 5mg; 25mg | N/A |
| TAMRA-PEG7-NH2 | NBS-230926 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NH2 | NBS-230927 | 5mg; 25mg | N/A |
| TAMRA-PEG2-NH2 | NBS-230928 | 5mg; 25mg | 1425379-69-6 |
| Me-Tet-PEG8-NHBoc | NBS-230929 | 100mg; 500mg | 2143968-21-0 |
| Me-Tet-PEG4-NHBoc | NBS-230930 | 100mg; 500mg | 2143955-71-7 |
| Me-Tet-PEG3-NHBoc | NBS-230931 | 100mg; 500mg | 2141976-32-9 |
| Biotin-PEG8-Me-Tet | NBS-230932 | 100mg; 500mg | 2143958-82-9 |
| Biotin-PEG4-Me-Tet | NBS-230933 | 100mg; 500mg | 1962919-31-8 |
| Biotin-PEG3-Me-Tet | NBS-230934 | 100mg; 500mg | 2143968-06-1 |
| Me-Tet-PEG9-COOH | NBS-230935 | 100mg; 500mg | 2143964-70-7 |
| Me-Tet-PEG5-COOH | NBS-230936 | 100mg; 500mg | 2143964-72-9 |
| Me-Tet-PEG4-COOH | NBS-230937 | 100mg; 500mg | 2141976-30-7 |
| Me-Tet-PEG9-NHS | NBS-230938 | 100mg; 500mg | 2143955-78-4 |
| Me-Tet-PEG5-NHS | NBS-230939 | 100mg; 500mg | 2096446-25-0 |
| Me-Tet-PEG4-NHS | NBS-230940 | 100mg; 500mg | 2143968-22-1 |
| Me-Tet-PEG8-Maleimide | NBS-230941 | 100mg; 500mg | 2143968-05-0 |
| Me-Tet-PEG4-Maleimide | NBS-230942 | 100mg; 500mg | 1715913-76-0 |
| Me-Tet-PEG3-Maleimide | NBS-230943 | 100mg; 500mg | 2141976-31-8 |
| Me-Tet-PEG8-NH2-HCl salt | NBS-230944 | 100mg; 500mg | 2143958-58-9 (H+) |
| Me-Tet-PEG4-NH2 | NBS-230945 | 100mg; 500mg | 2055646-21-2 |
| Me-Tet-PEG3-NH2 | NBS-230946 | 100mg; 500mg | 2141976-28-3 |
| Biotin-PEG8-Alkyne | NBS-230947 | 100mg; 500mg | 2143968-80-1 |
| Biotin-PEG4-Alkyne | NBS-230948 | 100mg; 500mg | 1262681-31-1 |
| Biotin-PEG3-Alkyne | NBS-230949 | 100mg; 500mg | 1421701-68-9 |
| Biotin-PEG7-N3 | NBS-230950 | 100mg; 500mg | 1334172-75-6 |
| Biotin-PEG3-N3 | NBS-230951 | 100mg; 500mg | 875770-34-6 |
| Biotin-PEG2-N3 | NBS-230952 | 100mg; 500mg | 945633-30-7 |
| Biotin-PEG8-COOH | NBS-230953 | 100mg; 500mg | 2143964-62-7 |
| Biotin-PEG4-COOH | NBS-230954 | 100mg; 500mg | 721431-18-1 |
| Biotin-PEG3-COOH | NBS-230955 | 100mg; 500mg | 252881-76-8 |
| Biotin-PEG8-NHS | NBS-230956 | 100mg; 500mg | 2143968-03-8 |
| Biotin-PEG4-NHS | NBS-230957 | 100mg; 500mg | 459426-22-3 |
| Biotin-PEG3-NHS | NBS-230958 | 100mg; 500mg | 1253286-56-4 |
| Biotin-PEG7-Maleimide | NBS-230959 | 100mg; 500mg | 1898221-65-2 |
| Biotin-PEG3-Maleimide | NBS-230960 | 100mg; 500mg | 1431618-70-0 |
| Biotin-PEG2-Maleimide | NBS-230961 | 100mg; 500mg | 305372-39-8 |
| Biotin-PEG7-NH2 | NBS-230962 | 100mg; 500mg | 1334172-76-7 |
| Biotin-PEG3-NH2 | NBS-230963 | 100mg; 500mg | 359860-27-8 |
| Biotin-PEG2-NH2 | NBS-230964 | 100mg; 500mg | 138529-46-1 |
| TCO4-PEG8-COOH | NBS-230965 | 100mg; 500mg | N/A |
| TCO*-PEG8-COOH | NBS-230966 | 100mg; 500mg | N/A |
| TCO*-PEG4-COOH | NBS-230967 | 100mg; 500mg | N/A |
| TCO4-PEG4-COOH | NBS-230968 | 100mg; 500mg | 1802913-21-8 |
| TCO4-PEG3-COOH | NBS-230969 | 100mg; 500mg | 2141981-86-2 |
| TCO*-PEG3-COOH | NBS-230970 | 100mg; 500mg | N/A |
| TCO*-PEG8-NHS | NBS-230971 | 100mg; 500mg | N/A |
| TCO4-PEG8-NHS | NBS-230972 | 100mg; 500mg | N/A |
| TCO4-PEG4-NHS | NBS-230973 | 100mg; 500mg | 1621096-79-4 |
| TCO*-PEG4-NHS | NBS-230974 | 100mg; 500mg | N/A |
| TCO*-PEG3-NHS | NBS-230975 | 100mg; 500mg | N/A |
| TCO4-PEG3-NHS | NBS-230976 | 100mg; 500mg | 2141981-88-4 |
| TCO*-PEG7-Maleimide | NBS-230977 | 100mg; 500mg | N/A |
| TCO*-PEG3-Maleimide | NBS-230978 | 100mg; 500mg | 2392039-23-3 |
| TCO*-PEG2-Maleimide | NBS-230979 | 100mg; 500mg | N/A |
| TCO4-PEG7-Maleimide | NBS-230980 | 100mg; 500mg | N/A |
| TCO4-PEG3-Maleimide | NBS-230981 | 100mg; 500mg | 1914971-04-2 |
| TCO4-PEG2-Maleimide | NBS-230982 | 100mg; 500mg | 2141981-85-1 |
| TCO*-PEG2-NH2 | NBS-230983 | 100mg; 500mg | N/A |
| TCO*-PEG3-NH2 | NBS-230984 | 100mg; 500mg | N/A |
| TCO*-PEG7-NH2 | NBS-230985 | 100mg; 500mg | N/A |
| TCO4-PEG7-NH2 | NBS-230986 | 100mg; 500mg | N/A |
| TCO4-PEG3-NH2 | NBS-230987 | 100mg; 500mg | 1800507-93-0 |
| TCO4-PEG2-NH2 | NBS-230988 | 100mg; 500mg | N/A |
| SCO-PEG7-Maleimide | NBS-230989 | 100mg; 500mg | 2143968-81-2 |
| SCO-PEG3-Maleimide | NBS-230990 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG2-Maleimide | NBS-230991 | 100mg; 500mg | 2141976-23-8 |
| BCN-exo-PEG7-Maleimide | NBS-230992 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-Maleimide | NBS-230993 | 100mg; 500mg | N/A |
| BCN-exo-PEG2-Maleimide | NBS-230994 | 100mg; 500mg | 2141976-22-7 |
| BCN-endo-PEG7-Maleimide | NBS-230995 | 100mg; 500mg | N/A |
| BCN-endo-PEG3-Maleimide | NBS-230996 | 100mg; 500mg | 2141976-33-0 |
| BCN-endo-PEG2-Maleimide | NBS-230997 | 100mg; 500mg | N/A |
| BCN-exo-PEG8-COOH | NBS-230998 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-COOH | NBS-230999 | 100mg; 500mg | 1421932-54-8 |
| BCN-exo-PEG3-COOH | NBS-231000 | 100mg; 500mg | 1807501-82-1 |
| BCN-exo-PEG8-NHS | NBS-231001 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-NHS | NBS-231002 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-NHS | NBS-231003 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG3-NHS | NBS-231004 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG4-NHS | NBS-231005 | 100mg; 500mg | 1702356-19-1 |
| BCN-endo-PEG8-NHS | NBS-231006 | 100mg; 500mg | 1608140-48-2 |
| BCN-endo-PEG8-COOH | NBS-231007 | 100mg; 500mg | N/A |
| BCN-endo-PEG4-COOH | NBS-231008 | 100mg; 500mg | 1881221-47-1 |
| BCN-endo-PEG3-COOH | NBS-231009 | 100mg; 500mg | 1807501-82-1 |
| SCO-PEG3-COOH | NBS-231010 | 100mg; 500mg | 2141976-36-3 |
| SCO-PEG4-COOH | NBS-231011 | 100mg; 500mg | 2141976-27-2 |
| SCO-PEG8-COOH | NBS-231012 | 100mg; 500mg | 2143968-79-8 |
| SCO-PEG8-NHS | NBS-231013 | 100mg; 500mg | 2143968-68-5 |
| SCO-PEG4-NHS | NBS-231014 | 100mg; 500mg | 2141976-26-1 |
| SCO-PEG3-NHS | NBS-231015 | 100mg; 500mg | 2141976-25-0 |
| SCO-PEG7-NH2 | NBS-231016 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG3-NH2 | NBS-231017 | 100mg; 500mg | 2141976-29-4 |
| SCO-PEG2-NH2 | NBS-231018 | 100mg; 500mg | 2141976-34-1 |
| BCN-exo-PEG2-NH2 | NBS-231019 | 100mg; 500mg | 1357379-13-5 |
| BCN-exo-PEG3-NH2 | NBS-231020 | 100mg; 500mg | 1841134-72-2 |
| BCN-exo-PEG7-NH2 | NBS-231021 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG7-NH2 | NBS-231022 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG3-NH2 | NBS-231023 | 100mg; 500mg | 1883512-27-3 |
| BCN-endo-PEG2-NH2 | NBS-231024 | 100mg; 500mg | 1263166-93-3 |
| PEG-12 | NBS-231025 | 1g; 10g; bulk | 6790-09-6 |
| PEG-11 | NBS-231026 | 1g; 10g; bulk | 6809-70-7 |
| PEG-10 | NBS-231027 | 1g; 10g; bulk | 5579-66-8 |
| PEG-9 | NBS-231028 | 1g; 10g; bulk | 3386-18-3 |
| PEG-8 | NBS-231029 | 1g; 10g; 100g; 1kg; bulk | 5117-19-1 |
| Alkyne-PEG2-TCA | NBS-231030 | 100mg | 1281695-03-1 |
| Azido-PEG2-TCA | NBS-231031 | 100mg | 1281695-02-0 |
| Alkyne-PEG2-CM | NBS-231032 | 100mg | 1281695-01-9 |
| Azido-PEG2-CM | NBS-231033 | 100mg | 1281695-00-8 |
| Alkyne-PEG2 | NBS-231034 | 100mg | 7218-43-1 |
| Azido-PEG1 | NBS-231035 | 100mg | 139115-90-5 |
| 2-Methyl-Glycerol | NBS-231036 | 10g; 100g | 25245-58-3 |
| 2-Stearoyl glycerol | NBS-231037 | 20mg; 100mg | 621-61-4 |
| 2-Palmitoyl glycerol | NBS-231038 | 20mg; 100mg | 23470-00-0 |
| 2-Myristoyl glycerol | NBS-231039 | 20mg; 100mg | 3443-83-2 |
| 2-Lauroyl glycerol | NBS-231040 | 20mg; 100mg | 1678-45-1 |
| 2-Linoleoyl glycerol | NBS-231041 | 100 mmol solution in ACN | 3443-82-1 |
| 2-Oleoyl-glycerol | NBS-231042 | 10mg; 100mg | 3443-84-3 |
| SH-6 | NBS-231043 | 1mg; 5mg | 701976-55-8 |
| SH-5 | NBS-231044 | 1mg; 5mg | 701976-54-7 |
| Ins(345)P3*3Na | NBS-231045 | 1mg | 112791-62-5 (H) / 911105-38-9 (6 Na) |
| Ins(1)P*2K | NBS-231046 | 5mg | 313263-16-0 / 15421-51-9 (H) |
| myo-Inositol-trispyrophosphate | NBS-231047 | 100mg | 623552-11-4 / 802590-64-3 / 23103-35-7 |
| Ins(123456)P6 | NBS-231048 | 5g; 25g | 83-86-3 / 14306-25-3 (sodium salt) |
| Ins(23456)P5*10Na | NBS-231049 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(13456)P5*10Na | NBS-231050 | 1mg | 20298-95-7 (H+) |
| Ins(12456)P5*10Na | NBS-231051 | 1mg | 183075-26-5 / 20298-94-6 (H+) |
| Ins(12356)P5*10Na | NBS-231052 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(12345)P5*10Na | NBS-231053 | 1mg | 183075-27-6 / 20298-96-8 (H+) |
| Ins(1345)P4*8Na | NBS-231054 | 1mg | 135269-51-1 (H+: 99610-76-1) |
| Ins(136)P3*6Na | NBS-231055 | 1mg | 93133-75-6 (H) |
| Ins(134)P3*6K | NBS-231056 | 1mg; 5mg | 140385-74-6 / 98102-63-7 (H) / 145920-23-6 (6Na) |
| Ins(345)P3*3K | NBS-231057 | 1mg | 348128-32-5 / 112791-62-5 (H) / 348128-47-2 (x*K) |
| Ins(145)P3*6K | NBS-231058 | 5mg | 103476-24-0 / 85166-31-0 (H) |
| Ins(145)P3*3Li | NBS-231059 | 5mg | 129828-69-9 / 85166-31-0 (H) |
| Ins(145)P3*6Na | NBS-231060 | 5mg | 108340-81-4 / 85166-31-0 (H) |
| Ins(135)P3*6Na | NBS-231061 | 1mg | N/A |
| Ins(1245)P4*8Na | NBS-231062 | 1mg | 170715-18-1 (H+: 117142-45-7) |
| Bt3-Ins(356)P3 / PM | NBS-231063 | 1 µmol | N/A |
| Bt3-Ins(346)P3 / PM | NBS-231064 | 1 µmol | 503158-16-5 |
| Bt3-Ins(146)P3 / PM | NBS-231065 | 1 µmol | 503158-17-6 |
| Bt3-Ins(135)P3 / PM | NBS-231066 | 1 µmol | 503158-15-4 |
| Bt2-Ins(3456)P4 / PM | NBS-231067 | 1 µmol | 1233512-98-5 |
| Bt2-Ins(1456)P4 / PM | NBS-231068 | 1 µmol | N/A |
| Bt2-Ins(1345)P4 / PM | NBS-231069 | 1 µmol | 503158-20-1 |
| Bt2-Ins(1356)P4 / AM | NBS-231070 | 1 µmol | 164199-43-3 |
| Bt3-Ins(356)P3 / AM | NBS-231071 | 1 µmol | 164199-42-2 |
| Bt3-Ins(346)P3 / AM | NBS-231072 | 1 µmol | 431900-03-7 |
| Bt3-Ins(146)P3 / AM | NBS-231073 | 1 µmol | 431900-02-6 |
| Bt3-Ins(134)P3 / AM | NBS-231074 | 1 µmol | 205247-51-4 |
| Bt3-Ins(136)P3 / AM | NBS-231075 | 1 µmol | N/A |
| Bt3-Ins(135)P3 / AM | NBS-231076 | 1 µmol | 1258008-22-8 |
| Bt3-Ins(145)P3 / AM | NBS-231077 | 1 µmol | 164007-69-6 (196954-45-7) |
| caged-Ins(145)P3 / PM | NBS-231078 | 10 * 10 µg | 1009832-82-9 |
| caged-Ins(145)P3 / PM | NBS-231079 | 100 µg | 1009832-82-9 |
| caged-Ins(145)P3O6 | NBS-231080 | 100 µg | 887903-55-1 (H+) |
| caged-Ins(145)P3 P4 | NBS-231081 | 100 µg | 119147-20-5 / 132204-31-0 |
| PtdIns(345)P3 | NBS-231082 | 1mg | 165689-82-7 |
| PtdIns(45)P2 | NBS-231083 | 1mg | 120595-88-2 / 213596-15-7 |
| PtdIns(34)P2 | NBS-231084 | 1mg | 165883-85-2 |
| PtdIns(5)P | NBS-231085 | 1mg | 291527-75-8 |
| PtdIns(4)P | NBS-231086 | 1mg | 57606-15-2 |
| PtdIns(3)P | NBS-231087 | 1mg | 165689-81-6 |
| PtdIns(1)P | NBS-231088 | 1mg | 62742-56-7 / 28366-80-5 |
| D-myo-Inositol-1,2-O-cyclohexylidene | NBS-231089 | 1g | 55123-25-6 (rac: 6763-47-9) |
| 23:45-diisopropylidene-myo-Inositol | NBS-231090 | 1g | 211294-75-6 |
| 12:56- diisopropylidene-myo-Inositol | NBS-231091 | 1g | 211294-79-0 |
| D-myo-Inositol-2,3-O-cyclohexylidene | NBS-231092 | 1g | 57029-87-5 |
| 2,3:4,5-Di-O-Iso-1,6-Di-O-Benzyl-Ins | NBS-231093 | 1g | 131233-62-0 / 1266500-90-6 |
| 1,2:5,6-Di-O-Iso-3,4-Di-O-Benzyl-Ins | NBS-231094 | 1g | 131233-62-0 / 1266500-90-6 |
| DEAC-dUTP | NBS-231095 | 25 nmol; 100 nmol | N/A |
| 35-PAPS-TEA | NBS-231096 | 5mg | 936827-87-1 |
| ACPPS-TEA | NBS-231097 | 5mg | 102029-54-9 / 62230-90-4 |
| 25-PAPS-Li | NBS-231098 | 5mg | 62230-89-1 / 102029-54-9 |
| 35-PAPS-Li (CAS: 102029-54-9) | NBS-231099 | 5mg | 102029-54-9 / 482-67-7 (H+) |
| EdUTP-TEA | NBS-231100 | 1mg | 1191275-46-3 |
| EdUTP | NBS-231101 | 1mg | 111289-87-3 |
| 2'-PAP | NBS-231102 | 10mg; 50mg | 3805-37-6 |
| 2'-PAP-Na | NBS-231103 | 10mg; 50mg | 108347-94-0 |
| 3'-PAP-Na | NBS-231104 | 10mg; 50mg | 75431-54-8 |
| 3'-PAP | NBS-231105 | 10mg; 50mg | 1053-73-2 |
| Vancomycin hexapeptide | NBS-231106 | 5mg; 10mg | 115236-65-2 |
| Didechloro Vancomycin | NBS-231107 | 20mg; 100mg | 98510-30-6 |
| Vancomycin Impurity A | NBS-231108 | 20mg; 100mg | 91700-98-0 |
| Vancomycin Impurity D | NBS-231109 | 5mg; 10mg | 101485-50-1 |
| Vancomycin Impurity C | NBS-231110 | 5mg; 10mg | 82198-76-3 |
| Vancomycin Impurity B | NBS-231111 | 20mg; 100mg | 55598-85-1 |
| INO-4995 | NBS-231112 | 1mg; 10mg | 868171-91-9 |
| Podophyllotoxin Derivate | NBS-231113 | 100mg | 6559-91-7 |
| Podophyllotoxin Derivate | NBS-231114 | 10mg | 117507-84-3 |
| Clopidogrel Impurity 4 | NBS-231115 | 100mg | 144457-43-2 |
| Gestodene Impurity E | NBS-231116 | 1mg; 10mg | N/A |
| Fidaxomicin Metabolite OP-1118 | NBS-231117 | 1mg; 10mg | 1030825-28-5 |
| Prasugrel metabolite M6-d3 (stabilzed) | NBS-231118 | 1mg | 1234692-58-0 (without d3) |
| Prasugrel metabolite M6 | NBS-231119 | 10mg | 947530-51-0 |
| Clopidogrel Impurity C | NBS-231120 | 10mg | 1346605-15-9 |
| Clopidogrel Impurity 3 | NBS-231121 | 10mg | 141109-18-4 |
| Prasugrel active metabolite M3 HCl (stabilized) | NBS-231122 | 1mg; 5mg | 1287383-06-5 |
| Fidaxomicin-d7 | NBS-231123 | 1mg; 10mg | 873857-62-6 (unlabeled) |
| Methyl 4-(2-hydroxyethyl)benzoate-13C6,2D (Ring-13C6,Ethyl-1,2-D2) | NBS-231124 | 10mg | N/A |
| Anthracene 13C6 | NBS-231125 | 10mg | 189811-60-7 |
| Phenanthrene 13C6 | NBS-231126 | 10mg | 1189955-53-0 |
| Naphthalene 13C10 | NBS-231127 | 10mg | 219526-41-7 |
| Naphthalene 13C6 | NBS-231128 | 10mg | 1192501-11-3 |
| Prasugrel active metabolite M3-d3 (stabilzed) | NBS-231129 | 1mg; 5mg | 1619986-66-1 / 1226870-93-4 (without HCl) |
| 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite | NBS-231130 | 10g | 89992-70-1 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(2-cyanoethyl) ester | NBS-231131 | 5g | 102690-88-0 |
| Phosphoramidous acid, N,N-bis(1-methylethyl)-, bis(phenylmethyl) ester | NBS-231132 | 10g | 108549-23-1 |
| Phosphorodiamidous acid. N.N.N'.N'-tetrakis(1-methylethyl)-. phenylmethyl ester | NBS-231133 | 1g | 108549-21-9 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. 2-cyanoethyl [1-(2-nitrophenyl)ethyl] ester) | NBS-231134 | 100mg | 461425-49-0 |
| Dichloro N,N-Diisopropylphosphoramidite | NBS-231135 | 10g | 921-26-6 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(9H-fluoren-9-ylmethyl) ester | NBS-231136 | 1g; 5g; 10g | 197709-11-8 |
| Di-tert-butyl chloromethyl phosphate | NBS-231137 | 1g | 229625-50-7 |
| Di-benzyl chloromethyl phosphate | NBS-231138 | 1g | 258516-84-6 |
| Ethyl 2-methyl-3-(trimethylsilyl)cycloprop-2-ene-1-carboxylate | NBS-231139 | 1g | 33002-26-5 |
| NOTA-Evans Blue / NEB | NBS-231140 | 1mg; 10mg | N/A |
| CoA-Cy5 | NBS-231141 | 1mg | N/A |
| CoA-Cy3 | NBS-231142 | 1mg | N/A |
| TMe-OHB-DAZA | NBS-231143 | 1mg; 10mg | 2241024-76-8 |
| NEmo2E | NBS-231144 | 10 µL; 50 µL | N/A |
| NEmo1 | NBS-231145 | 10 µL; 50 µL | N/A |
| Phycocyanobilin-PCB | NBS-231146 | 10mg; 25mg | 20298-86-6 |
| D-Serine-O-phosphate | NBS-231147 | 1g; 5g | 73913-63-0 |
| Ph-CCA-NH2 | NBS-231148 | 250mg | 129179-92-6 |
| Menaquinone 8 / MK 8:8 | NBS-231149 | 100 µg; 500 µg | 523-38-6 |
| Allyl-Maleimide | NBS-231150 | 100mg ; 500mg | 2973-17-3 |
| Nor-cisapride Derivative | NBS-231151 | 100mg; 1g | N/A |
| AlK-L-Lysine-HCl-salt | NBS-231152 | 2g; 5g | 6298-03-9 (H+) // 147529-99-5 (HCl) |
| 4-methyl-2,2-bis(trifluoromethyl)oxazolidin-5-one | NBS-231153 | 1g | 6458-31-7 |
| 3-(5-oxo-2,2-bis(trifluoromethyl)oxazolidin-4-yl)propanoic acid | NBS-231154 | 1g | 6458-51-1 |
| 7-(diethylamino)-4-(hydroxymethyl)-coumarin / DEACM | NBS-231155 | 100mg | 54711-38-5 |
| 3-bromo-4-methyl-7-(diethylamino)-coumarin | NBS-231156 | 100mg | 92295-93-7 |
| Xanthohumol | NBS-231157 | 10mg; 50mg | 6754-58-1 |
| IEPOX 4 | NBS-231158 | 5mg | 1189798-08-0 |
| IEPOX 3 | NBS-231159 | 5mg | 1189798-08-0 |
| 2-C-Methyl-L-Threitol | NBS-231160 | 5mg | 93921-84-7 |
| 2-C-Methyl-D-Threitol | NBS-231161 | 5mg | 310887-92-4 |
| 2-C-Methyl-L-Erythritol | NBS-231162 | 5mg | 93921-83-6 |
| 2-C-Methyl-D-Erythritol | NBS-231163 | 5mg | 58698-37-6 |
| 3-Amino-7-(diethylamino)-coumarine | NBS-231164 | 100mg; 500mg | 817638-67-8 |
| Chloromethylpropionate | NBS-231165 | 1g; 5g | 5402-53-9 |
| 2-(2-fluoro-2-methylpropoxy)-2-methylpropan-1-ol | NBS-231166 | 1g; 10g | 1823357-87-4 |
| 1,4-Di-butyryl-23:56-diisopropylidene-myo-Inositol | NBS-231167 | 0.5g; 1g | 1620222-02-7 |
| 3,6-Di-butyryl-12:45-diisopropylidene-myo-Inositol | NBS-231168 | 0.5g; 1g | 1307298-34-5 |
| Y-27632 | NBS-231169 | 50mg | 146986-50-7 |
| H-1152 | NBS-231170 | 10mg | 45146-2-58-1 |
| 3,4,5,6-Tetra-O-Benzyl-Ins | NBS-231171 | 1g | 24558-77-8 |
| 1,4,5,6-Tetra-O-Benzyl-Ins | NBS-231172 | 1g | 26276-99-3 |
| 2,5-Anhydro-6-azido-6-deoxy-1,3-O-isopropylidene-D-glucitol | NBS-231173 | 1g、5g、10g、25g、Bulk | N/A |
| 4-Azido-4-deoxy-1,6:2,3-dianhydro-β-D-mannopyranose | NBS-231174 | 1g、5g、10g、25g、Bulk | N/A |
| Methyl-3,6-anhydro-7-azido-2,7-dideoxy-4,5-O-isopropylidene-D-alloheptonate | NBS-231175 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-3-azido-2-O-benzoyl-3-deoxy-D-xylitol | NBS-231176 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-2-azido-3-O-benzoyl-2-deoxy-D-arabitol | NBS-231177 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,4;3,6-dianhydro-D-glucitol | NBS-231178 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-D-galactopyranose | NBS-231179 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-L-galactopyranose | NBS-231180 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA free acid | NBS-231181 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA monosodium salt | NBS-231182 | 1g、5g、10g、25g、Bulk | N/A |
| Glyco-DIBMA | NBS-231183 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl α-D-glucopyranoside | NBS-231184 | 1g、5g、10g、25g、Bulk | 29781-80-4 |
| HECAMEG | NBS-231185 | 1g、5g、10g、25g、Bulk | 115457-83-5 |
| n-Hexyl β-D-glucopyranoside | NBS-231186 | 1g、5g、10g、25g、Bulk | 59080-45-4 |
| n-Heptyl β-D-glucopyranoside | NBS-231187 | 1g、5g、10g、25g、Bulk | 78617-12-6 |
| n-Octyl β-D-glucopyranoside | NBS-231188 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Octyl β-D-glucopyranoside | NBS-231189 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Nonyl β-D-glucopyranoside | NBS-231190 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Nonyl β-D-glucopyranoside | NBS-231191 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Decyl β-D-glucopyranoside (DG) > 99% highly purified | NBS-231192 | 1g、5g、10g、25g、Bulk | 58846-77-8 |
| n-Undecyl β-D-glucopyranoside (UDG) | NBS-231193 | 1g、5g、10g、25g、Bulk | 70005-86-6 |
| n-Dodecyl β-D-glucopyranoside | NBS-231194 | 1g、5g、10g、25g、Bulk | 59122-55-3 |
| 4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-maltoside | NBS-231195 | 1g、5g、10g、25g、Bulk | N/A |
| n-Dodecyl α-maltoside | NBS-231196 | 1g、5g、10g、25g、Bulk | 116183-64-3 |
| n-Hexyl β-maltoside | NBS-231197 | 1g、5g、10g、25g、Bulk | 870287-95-9 |
| n-Heptyl β-maltoside | NBS-231198 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl β-maltoside | NBS-231199 | 1g、5g、10g、25g、Bulk | 82494-08-4 |
| n-Nonyl β-maltoside | NBS-231200 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Nonyl β-maltoside | NBS-231201 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Decyl β-maltoside | NBS-231202 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Decyl β-maltoside | NBS-231203 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Undecyl β-maltoside | NBS-231204 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Undecyl β-maltoside | NBS-231205 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Dodecyl β-maltoside | NBS-231206 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| n-Tridecyl β-maltoside | NBS-231207 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tridecyl β-maltoside | NBS-231208 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tetradecyl β-maltoside | NBS-231209 | 1g、5g、10g、25g、Bulk | 18449-82-6 |
| n-Pentadecyl β-maltoside | NBS-231210 | 1g、5g、10g、25g、Bulk | N/A |
| n-Hexadecyl β-maltoside | NBS-231211 | 1g、5g、10g、25g、Bulk | 98064-96-1 |
| n-Dodecyl β-maltoside | NBS-231212 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| Isopropyl 1-thio-β-D-galactopyranoside | NBS-231213 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231214 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231215 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| n-Nonyl 1-thio-β-D-glucopyranoside | NBS-231216 | 1g、5g、10g、25g、Bulk | 98854-15-0 |
| n-Decyl 1-thio-β-D-glucopyranoside | NBS-231217 | 1g、5g、10g、25g、Bulk | 98854-16-1 |
| n-Dodecyl 1-thio-β-maltoside | NBS-231218 | 1g、5g、10g、25g、Bulk | 148565-58-6 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231219 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231220 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| MEGA-8 | NBS-231221 | 1g、5g、10g、25g、Bulk | 85316-98-9 |
| MEGA-9 | NBS-231222 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| MEGA-10 | NBS-231223 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| 1-O-(n-Octyl)-tetraethyleneglycol | NBS-231224 | 1g、5g、10g、25g、Bulk | 19327-39-0 |
| 1-O-(n-Decyl)-hexaethyleneglycol (C10E6) | NBS-231225 | 1g、5g、10g、25g、Bulk | 5168-89-8 |
| 1-O-(n-Decyl)-nonaethyleneglycol | NBS-231226 | 1g、5g、10g、25g、Bulk | 26183-52-81 |
| 1-O-(n-Dodecyl)-tetraethyleneglycol | NBS-231227 | 1g、5g、10g、25g、Bulk | 5274-68-0 |
| 1-O-(n-Dodecyl)-octaethyleneglycol | NBS-231228 | 1g、5g、10g、25g、Bulk | 3055-98-9 |
| 1-O-(n-Dodecyl)-nonaethyleneglycol | NBS-231229 | 1g、5g、10g、25g、Bulk | 3055-99-0 |
| 1-O-(n-Dodecyl)-decaethyleneglycol | NBS-231230 | 1g、5g、10g、25g、Bulk | 6540-99-4 |
| 1-O-(n-Tridecyl)-octaethyleneglycol | NBS-231231 | 1g、5g、10g、25g、Bulk | 9043-30-5 |
| N,N-Dimethyl-n-dodecylamine-N-oxide | NBS-231232 | 1g、5g、10g、25g、Bulk | 1643-20-5 |
| Sucrose monolaurate | NBS-231233 | 1g、5g、10g、25g、Bulk | 25339-99-5 |
| Monoolein | NBS-231234 | 1g、5g、10g、25g、Bulk | 111-03-5 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfonate | NBS-231235 | 1g、5g、10g、25g、Bulk | 75621-03-3 |
| CHAPSO | NBS-231236 | 1g、5g、10g、25g、Bulk | 82473-24-3 |
| n-Nonylphosphocholine | NBS-231237 | 1g、5g、10g、25g、Bulk | 253678-64-7 |
| n-Decylphosphocholine | NBS-231238 | 1g、5g、10g、25g、Bulk | 70504-28-8 |
| n-Undecylphosphocholine | NBS-231239 | 1g、5g、10g、25g、Bulk | 253678-65-8 |
| n-Dodecylphosphocholine | NBS-231240 | 1g、5g、10g、25g、Bulk | 29557-51-5 |
| n-Tridecylphosphocholine | NBS-231241 | 1g、5g、10g、25g、Bulk | 85775-42-4 |
| n-Tetradecylphosphocholine | NBS-231242 | 1g、5g、10g、25g、Bulk | 77733-28-9 |
| n-Pentadecylphosphocholine | NBS-231243 | 1g、5g、10g、25g、Bulk | 146801-07-2 |
| n-Hexadecylphosphocholine | NBS-231244 | 1g、5g、10g、25g、Bulk | 58066-85-6 |
| α-D-Galactopyranose-phosphate di-potassium salt dihydrate | NBS-231245 | 1g、5g、10g、25g、Bulk | 19046-60-7 |
| α-D-Glucopyranose-phosphate di-potassium salt dihydrate | NBS-231246 | 1g、5g、10g、25g、Bulk | 5996-14-5 |
| α-D-Mannopyranose-phosphate di-potassium salt dihydrate | NBS-231247 | 1g、5g、10g、25g、Bulk | 71888-67-0 |
| N-Acetyl-D-galactosamine | NBS-231248 | 1g、5g、10g、25g、Bulk | 1811-31-0 |
| N-Acetyl-D-glucosamine | NBS-231249 | 1g、5g、10g、25g、Bulk | 7512-17-6 |
| 2-Acetamido-2-deoxy-β-D-glucopyranosylamin | NBS-231250 | 1g、5g、10g、25g、Bulk | 18615-50-4 |
| 2-Acetamido-2-deoxy-D-mannose monohydrate | NBS-231251 | 1g、5g、10g、25g、Bulk | 7772-94-3 |
| 1,3,4,6-tetra-O-acetyl-β-D-GlcNAc | NBS-231252 | 1g、5g、10g、25g、Bulk | 7772-79-4 |
| 3,4,6-tri-O-acetyl-β-D-GlcNAc azide | NBS-231253 | 1g、5g、10g、25g、Bulk | 6205-69-2 |
| 3,4,6-tri-O-acetyl-α-D-GlcNAc chlorid | NBS-231254 | 1g、5g、10g、25g、Bulk | 3068-34-6 |
| 1,3,4,6-tetra-O-acetyl-α-D-glucosamine x HCl | NBS-231255 | 1g、5g、10g、25g、Bulk | N/A |
| Allyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231256 | 1g、5g、10g、25g、Bulk | 54400-75-8 |
| Allyl 2-acetamido-2-deoxy-β-D-glucopyranoside | NBS-231257 | 1g、5g、10g、25g、Bulk | 54400-77-0 |
| Allyl α-D-galactopyranoside | NBS-231258 | 1g、5g、10g、25g、Bulk | 48149-72-0 |
| Allyl α-D-glucopyranoside | NBS-231259 | 1g、5g、10g、25g、Bulk | 7464-56-4 |
| Allyl β-D-glucopyranoside | NBS-231260 | 1g、5g、10g、25g、Bulk | 34384-797 |
| Allyl α-D-mannopyranoside | NBS-231261 | 1g、5g、10g、25g、Bulk | 41308-76-3 |
| Allyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside | NBS-231262 | 1g、5g、10g、25g、Bulk | N/A |
| 1-Amino-1-deoxy-β-D-galactose | NBS-231263 | 1g、5g、10g、25g、Bulk | 50444-86-5 |
| 1,6-Anhydro-β-D-galactopyranose | NBS-231264 | 1g、5g、10g、25g、Bulk | 644-76-8 |
| 1,6:3,4-Dianhydro-2-O-tosyl--D-galactopyranose | NBS-231265 | 1g、5g、10g、25g、Bulk | 6167-32-4 |
| D-Arabinose | NBS-231266 | 1g、5g、10g、25g、Bulk | 28697-53-2 |
| Arbutin | NBS-231267 | 1g、5g、10g、25g、Bulk | 497-76-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-galactopyranose | NBS-231268 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galacto-pyranose | NBS-231269 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose | NBS-231270 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,2‘,3,3‘,4‘,6,6‘-hepta-O-acetyl-α,β-lactose | NBS-231271 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-mannopyranose | NBS-231272 | 1g、5g、10g、25g、Bulk | N/A |
| Benzyl 4,6-O-benzylidene-α-D-GlcNAc | NBS-231273 | 1g、5g、10g、25g、Bulk | 13343-63-0 |
| Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231274 | 1g、5g、10g、25g、Bulk | 13343-62-9 |
| Benzyl α-D-mannopyranoside | NBS-231275 | 1g、5g、10g、25g、Bulk | 155548-45-5 |
| Cellobiose | NBS-231276 | 1g、5g、10g、25g、Bulk | 528-50-7 |
| 6-Deoxy-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose | NBS-231277 | 1g、5g、10g、25g、Bulk | 4026-27-1 |
| 3,4-Di-O-acetyl-L-rhamnal | NBS-231278 | 1g、5g、10g、25g、Bulk | 34819-86-8 |
| 1,4:3,6-Dianhydro-D-mannitol | NBS-231279 | 1g、5g、10g、25g、Bulk | 641-74-7 |
| 1,2,3,4-Di-O-isopropylidene-α-D-galactopyranose | NBS-231280 | 1g、5g、10g、25g、Bulk | 4064-06-6 |
| 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose | NBS-231281 | 1g、5g、10g、25g、Bulk | 582-52-5 |
| 1,2:5,6-Di-O-isopropylidene-D-mannitol | NBS-231282 | 1g、5g、10g、25g、Bulk | 1707-77-3 |
| 2,3:5,6-Di-O-isopropylidene-α-D-mannofuranose | NBS-231283 | 1g、5g、10g、25g、Bulk | 14131-84-1 |
| 1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose | NBS-231284 | 1g、5g、10g、25g、Bulk | 20881-04-3 |
| D-Fucose | NBS-231285 | 1g、5g、10g、25g、Bulk | 3615-37-0 |
| L-Fucose | NBS-231286 | 1g、5g、10g、25g、Bulk | 2438-80-4 |
| D-Galactosamine x HCl | NBS-231287 | 1g、5g、10g、25g、Bulk | 1172-03-8 |
| D-Glucosamine x HCl | NBS-231288 | 1g、5g、10g、25g、Bulk | 66-84-2 |
| L-Glucose | NBS-231289 | 1g、5g、10g、25g、Bulk | 921-60-8 |
| 2,3,3’,4,6,6’-Hexa-O-acetyl-lactal | NBS-231290 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2-O-Isopropylidene-α-D-glucofuranose | NBS-231291 | 1g、5g、10g、25g、Bulk | 18549-40-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231292 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231293 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| 3,4-O-Isopropylidene-D-mannitol | NBS-231294 | 1g、5g、10g、25g、Bulk | 369-84-4 |
| 1,2-O-Isopropylidene-α-D-xylofuranose | NBS-231295 | 1g、5g、10g、25g、Bulk | 20031-21-4 |
| D-Lyxose | NBS-231296 | 1g、5g、10g、25g、Bulk | 1114-34-7 |
| L-Lyxose | NBS-231297 | 1g、5g、10g、25g、Bulk | 1949-78-6 |
| Maltose monohydrate | NBS-231298 | 1g、5g、10g、25g、Bulk | 6363-53-7 |
| β-Maltose octaacetate | NBS-231299 | 1g、5g、10g、25g、Bulk | 22352-19-8 |
| D-Mannose | NBS-231300 | 1g、5g、10g、25g、Bulk | 3458-28-4 |
| L-Mannose | NBS-231301 | 1g、5g、10g、25g、Bulk | 10030-80-5 |
| Methyl 4,6-O-benzylidene-β-D-galactopyranoside | NBS-231302 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 4,6-O-benzylidene-α-D-glucopyranoside | NBS-231303 | 1g、5g、10g、25g、Bulk | 3162-96-7 |
| Methyl 4,6-O-benzylidene-β-D-glucopyranoside | NBS-231304 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 6-deoxy-α-L-mannopyranoside | NBS-231305 | 1g、5g、10g、25g、Bulk | 15814-59-2 |
| Methyl α-D-fucopyranoside | NBS-231306 | 1g、5g、10g、25g、Bulk | 1128-40-1 |
| Methyl α-L-fucopyranoside | NBS-231307 | 1g、5g、10g、25g、Bulk | 14687-15-1 |
| Methyl β-D-galactopyranoside | NBS-231308 | 1g、5g、10g、25g、Bulk | 1824-94-8 |
| Methyl β-D-glucopyranoside hemihydrate | NBS-231309 | 1g、5g、10g、25g、Bulk | 7000-27-3 |
| Methyl β-D-ribopyranoside | NBS-231310 | 1g、5g、10g、25g、Bulk | 17289-61-1 |
| Methyl 2,3,5-tri-O-benzoyl-α-D-arabinofuranoside | NBS-231311 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranose | NBS-231312 | 1g、5g、10g、25g、Bulk | 4163-60-4 |
| 1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose | NBS-231313 | 1g、5g、10g、25g、Bulk | 4163-65-9 |
| D-Raffinose pentahydrate | NBS-231314 | 1g、5g、10g、25g、Bulk | 17629-30-0 |
| L-Rhamnose monohydrate | NBS-231315 | 1g、5g、10g、25g、Bulk | 10030-85-0 |
| D-Ribose | NBS-231316 | 1g、5g、10g、25g、Bulk | 50-69-1 |
| L-Ribose | NBS-231317 | 1g、5g、10g、25g、Bulk | 24259-59-4 |
| D-Tagatose | NBS-231318 | 1g、5g、10g、25g、Bulk | 87-81-0 |
| α-D-Talose | NBS-231319 | 1g、5g、10g、25g、Bulk | 2595-98-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | NBS-231320 | 1g、5g、10g、25g、Bulk | 13992-26-2 |
| 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide | NBS-231321 | 1g、5g、10g、25g、Bulk | 3068-32-4 |
| 2,3,4,6-Tetra-O-acetyl--D-glucopyranosyl azide | NBS-231322 | 1g、5g、10g、25g、Bulk | 13992-25-1 |
| 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide | NBS-231323 | 1g、5g、10g、25g、Bulk | 572-09-8 |
| 1,3,4,6-Tetra-O-acetyl-β-D-mannopyranose | NBS-231324 | 1g、5g、10g、25g、Bulk | 18968-05-3 |
| 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranose | NBS-231325 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose | NBS-231326 | 1g、5g、10g、25g、Bulk | 13035-61-5 |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranose | NBS-231327 | 1g、5g、10g、25g、Bulk | N/A |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranose | NBS-231328 | 1g、5g、10g、25g、Bulk | 19879-84-6 |
| 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranose | NBS-231329 | 1g、5g、10g、25g、Bulk | 5308-25-7 |
| 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranose | NBS-231330 | 1g、5g、10g、25g、Bulk | 4132-28-9 |
| 2,3,4,6-Tetra-O-benzyl-α-D-mannopyranose | NBS-231331 | 1g、5g、10g、25g、Bulk | 61330-61-8 |
| 1-Thio-β-D-galactose sodium salt | NBS-231332 | 1g、5g、10g、25g、Bulk | 42891-22-5 |
| 1-Thio-β-D-glucose sodium salt dihydrate | NBS-231333 | 1g、5g、10g、25g、Bulk | 10593-29-0 |
| 3,4,6-Tri-O-acetyl-D-galactal | NBS-231334 | 1g、5g、10g、25g、Bulk | 4098-06-0 |
| D-Turanose | NBS-231335 | 1g、5g、10g、25g、Bulk | 547-25-1 |
| D-Xylose | NBS-231336 | 1g、5g、10g、25g、Bulk | 58-86-6 |
| 1,6-Anhydro-β-D-glucopyranose | NBS-231337 | 1g、5g、10g、25g、Bulk | 498-07-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose | NBS-231338 | 1g、5g、10g、25g、Bulk | N/A |

Stemmera公司位于美国加州,主要生产干细胞相关产品,包括检测试剂盒、培养基、抗体、缓冲液,还包括用于干细胞研究的细胞系。
Stemmera Inc is a privately owned biotechnology company located in Bay Area, California that focus in developing innovative technology and application solution for stem cell research. Our products include kit, culture medium, reagents, antibodies, buffer and solution, cell lines that are convenient tools used in stem cell research.
Stemmera公司主要产品:
(1)Kit
Alkaline Phosphatase (AP) Detection Kit (Ready-to-use)-Blue
Alkaline Phosphatase (AP) Detection Kit (Ready-to-use)-Red
Human Fibroblast (hFIB) Reprogramming Kit
Human Blood Cell (hBLD) Reprogramming Kit
(2)Media
Human ESCs/iPSCs Serum-/ Feeder-Free Medium (hStemSFM)
Human ESCs/iPSCs Xeno-Free Medium (hStemXFM)
Human Fibroblast (hFIB) Reprogramming Medium
Human Blood Cell (hBLD) Reprogramming Medium
Fibroblast Growth Medium
(3)Buffer & Solutions
Non-Enzymatic Cell Dissociation Solution (1X)
Serum-Free Cryopreservation Solution for Human ESCs/iPSCs
0.2% Gelatin
0.1% Gelatin
Universal Cryopreservation Solution
Blood Cell Cryopreservation Solution (1x)
Cell Fixation Solution (4% Paraformaldehyde, PFA)
Cell Fixation Solution (10% Formalin)
Metaphase Arrest Solution (10 μg/ml, 10X)
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://gbiosciences.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Stemmera"> Stemmera
RNAssist专注于单细胞分析中生物大分子的稳定剂研发,其专利性的产品在保障RNA和生物分子稳定性的同时,还可以有效保存细胞形态,和使病毒/细菌失活。三个系列的产品,包括vivoPHIX™, genoPHIX™和virusPHIX™,他们都能够对临床样本提供有效保护和灭活病原体,同时各自又有不同的功效,适用于细胞&组织固定、ISH、IF、scRNA-seq、二代测序等领域。
<【vivoPHIX】
vivoPHIX™ 单细胞组学专用组织RNA稳定剂,10ml
vivoPHIX™ (10ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-10
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,20ml
vivoPHIX™ (20ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-20
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,30ml
vivoPHIX™ (30ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-30
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,50ml
vivoPHIX™ (50ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-50
vivoPHIX™单细胞组学专用组织RNA稳定剂,可以用于组织中RNA的固定保存,特别适合后续多组学检测,包括scRNA-seq试验和SMART-seq试验。其发挥的作用包括:生物分子的稳定(RNA、DNA和磷酸化蛋白)、细胞固定、组织分离和病毒/细菌灭活。
<【genoPHIX】
genoPHIX™ 全组分组织稳定剂,20ml
genoPHIX™ 20ml: For projects involving large tissue samples
货号:RD-GENO-20
<genoPHIX™ 全组分组织稳定剂,50ml
genoPHIX™ 50ml: For projects involving large tissue samples
货号:RD-GENO-50
genoPHIX™ 全组分组织稳定剂,适合应用于石蜡包埋组织样品。其独特的性质,使得这个试剂可以从石蜡包埋组织中提取核酸并保持其稳定性,是IHC、IF、FISH、荧光蛋白检测的理想选择。
【virusPHIX】
<virusPHIX™ – RNA Stabiliser and virus inactivation reagent
virusPHIX™ RNA稳定及病毒灭活试剂
货号:N/A
(1)稳定组织样品中的RNA、DNA和磷酸化蛋白;
(2)对组织样品中病毒、细菌、酵母进行有效灭活,提高生物安全性;
(3)适合分子测试;
(4)可与多种RNA提取试剂盒配合使用,包括:RNeasy™, QIAamp™, QIAsymphony™, QIAcube™, Nuclisens™, GeneXpert™and Filmarray™
(5)无毒、稳定、常温运输。
< " data-original="http://gbiosciences.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="RNAssist系列稳定剂(virusPHIX™、genoPHIX™、vivoPHIX™)"> RNAssist系列稳定剂(virusPHIX™、genoPHIX™、vivoPHIX™)
艾美捷科技代理Quartett品牌
Quartett公司于1986年在德国柏林创立,始终致力于癌症防治领域并推动肿瘤诊断技术革新。quartett专注于两大核心业务:为解剖病理学/免疫组化(IHC)领域生产单克隆抗体,同时为制药工业及科研机构提供合成多肽产品。
▍Quartett两大核心技术
● 兔源重组单克隆抗体技术平台:突破传统鼠源抗体的局限。相较于鼠类免疫系统,兔源免疫系统具有显著优势——可识别更微小表位(≤5个氨基酸)、产生亲和力达10⁻¹²M的高特异性抗体,这使得quartett公司开发的诊断试剂在癌症检测中展现出卓越性能(如PD-L1检测灵敏度92.7%)。
● 合成肽制备技术:专业生产HPLC纯度>95%的定制肽,包括蛋白酶抑制剂及抗体生产用免疫原肽。该平台的成功更直接推动了兔源重组抗体技术的突破性发展,形成从合成肽到高价值诊断抗体的完整技术闭环。所有试剂均优化适配全自动染色平台(如Roche Ventana/Leica BOND)及人工染色流程。

▍Quartett部分产品列表
| 品名 | 货号 | Application | Host | Subclass | 规格 |
| CD31 (QR034) | C-C031-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| ERG (QR040) | C-E003-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Arginase-1 (QR083) | C-A003-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cadherin 17(QR098) | C-C036-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| CD117 (QR012) | P-C003-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| CD171/L1CAM (QR039) | C-C025-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| CDX2 (QR045) | P-C016-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 20 (Ks20.8) | C-C005-01 | IHC (FFPE) | Mouse | IgG2a/k | 0.1 ml concentrate |
| Glutamine synthetase (QR090) | P-G003-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Glypican 3 (QR103) | C-G005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| HSP70 (QR087) | P-H002-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| MLH1 (QM003) | C-M001-01 | IHC (FFPE) | Mouse | IgG2a/IgK | 0.1 ml concentrate |
| MSH2 (QR010) | P-M004-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| MSH6 (QR011) | C-M005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| PMS2 (QR009) | P-P005-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| SATB2 (QR023) | C-S002-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| SMAD4 (QR029) | P-S007-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| BAP1 (QR119) | C-B005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 14 (QR057) | P-C033-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 5 (QR027) | C-C008-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 5/14 (QR027/QR057) | P-C035-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 5/6 (QR027/QR028) | C-C017-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 6 (QR028) | C-C009-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 7 (QR049) | P-C014-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 8 (QR112) | C-C040-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin pan (MNF-116) | P-C034-150 | IHC (FFPE) | Mouse | IgG1/k | 15 ml Ready to use |
| EpCAM (QR107) | C-E006-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| GLUT1 (QR082) | P-G004-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Inhibin alpha (QR088) | C-I004-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| NUT (QR043) | P-N001-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| p21 (QR085) | C-P017-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| p53 (QR025) | P-P011-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |

Premetek公司致力于为学术客户和工业客户提供化学试剂、纳米材料和催化剂,同时也提供多领域的研发服务。通过不断地与业内专业企业进行技术整合,Premetek不断更新产品,并为材料科学和催化领域提供了最多样化和可扩展的选择。
Our retail objectives are to offer the most expansive selection of premium products, provide easy and friendly service, offer the fastest delivery time possible, and ensure that every customer is satisfied with their purchase. Our inventory is determined by extensive market research, attendance at international tradeshows and conferences, customer feedback, and working closely with industry experts and vendors. Premetek is committed to continually improving our services and being the premier online market place for all your needs.
Premetek公司的主要产品包括:
Nanomaterials
Nanomaterial Suspension
Pt,Pd Catalysts -Hydrogenation
Pt,Pd Catalysts -Red/Oxidation
Pt Catalysts - Electrochemistry
Pt Alloy Catalysts - Electrochemistry
Pd Alloy Catalysts - Electrochemistry
Pd,Ru,Ir,Rh,Au Catalysts - Electrochemistry
Fe,Co,Ni,Cu,Ag Catalysts - Electrochemistry
Pt,Pd,Ru,Ir,Rh,Au-Organometallics
Pt, Pd, Rh Homogeneous Catalysts
Custom Products
Special catalysts in stock
| 品名 | 货号 | 规格 |
| Aluminum titanate, Al2TiO5, 40 g each | N10A1000 | 40g |
| Barium strontium titanium oxide, BaSrTi2O6, 40 g each | N10B2000 | 40g |
| Calcium titanate, CaTiO3, 40 g each | N10C1000 | 40g |
| Calcium zirconium titanium oxide, CaZrTi2O3, 40 g each | N10C2000 | 40g |
| Cadmium tungsten oxide, CdWO4, 40 g each | N10C3000 | 40g |
| Cerium aluminate, CeAlO3, 40 g each | N10C4000 | 40g |
| Copper aluminate, CuAl2O4, 40 g each | N10C5000 | 40g |
| Iron nickel oxide, FeNiO4, 40 g each | N10I1000 | 40g |
| Lanthanum chromite, LaCrO3, 40 g each | N10L1000 | 40g |
| Lanthanum manganite , LaMnO3, 40 g each | N10L3000 | 40g |
| Lanthanum substituted lithium titanate, (LaLi3)TiO3, 40 g each | N10L5000 | 40g |
| Lead zirconium substituted titanate, PbZr0.2Ti0.8O3, 40 g each | N10L6000 | 40g |
| Manganese titanate, MnTiO3, 40 g each | N10M1000 | 40g |
| Magnesium aluminate, MgAl2O4, 40 g each | N10M2000 | 40g |
| Nickel cobalt oxide, NiCoO2, 40 g each | N10N1000 | 40g |
| Strontium bismuth niobium oxide, SrBi2Nb2O9, 50 g each | N10S1000 | 40g |
| Strontium ferrite, SrFe12O19, 40 g each | N10S2000 | 40g |
| Yttrium aluminum oxide, Y3Al5O12, 40 g each | N10Y1000 | 40g |
| Yttrium iron oxide, Y3Fe5O12, 40 g each | N10Y2000 | 40g |
| Zinc iron oxide, ZnFe2O4, 40 g each | N10Z1000 | 40g |
| Zinc titanium oxide, ZnTiO3, 40 g each | N10Z2000 | 40g |
| Concentrated Suspension of Nanoscaled Titanium Dioxide (TiO2), 5 kg | N-1000 | 5kg |
| Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg | N-2000 | 5kg |
| Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg | N-2010 | 5kg |
| Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3000 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3010 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3020 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3130 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3220 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3230 | 5kg |
| 0.1% Pt on activated carbon powder, 10 g each | P10J1001 | 10g |
| 0.5% Pt on activated carbon powder, 10 g each | P10J1005 | 10g |
| 1.0% Pt on activated carbon powder, 10 g each | P10J1010 | 10g |
| 5.0% Pt on activated carbon powder, 10 g each | P10J1050 | 10g |
| 10% Pt on activated carbon powder, 10 g each | P10J1100 | 10g |
| 20% Pt on activated carbon powder, 10 g each | P10J1200 | 10g |
| 0.1% Pt on granular carbon, 10 g each | P10J2001 | 10g |
| 0.5% Pt on granular carbon, 10 g each | P10J2005 | 10g |
| 1.0% Pt on granular carbon, 10 g each | P10J2010 | 10g |
| 5.0% Pt on granular carbon, 10 g each | P10J2050 | 10g |
| 0.1% Pd on activated carbon powder, 10 g each | P30J1001 | 10g |
| 0.5% Pd on activated carbon powder, 10 g each | P30J1005 | 10g |
| 1.0% Pd on activated carbon powder, 10 g each | P30J1010 | 10g |
| 5.0% Pd on activated carbon powder, 10 g each | P30J1050 | 10g |
| 10% Pd on activated carbon powder, 10 g each | P30J1100 | 10g |
| 20% Pd on activated carbon powder, 10 g each | P30J1200 | 10g |
| 0.1% Pd on granular carbon, 10 g each | P30J2001 | 10g |
| 0.3% Pd on granular carbon, 10 g each | P30J2003 | 10g |
| 0.5% Pd on granular carbon, 10 g each | P30J2005 | 10g |
| 1.0% Pd on granular carbon, 10 g each | P30J2010 | 10g |
| 5.0% Pd on granular carbon, 10 g each | P30J2050 | 10g |
| 0.5% Pd on alumina spheres, 3 mm, SA= | P30L1005 | 10g |
| 1.0% Pd on alumina spheres, 3 mm, SA= | P30L1010 | 10g |
| 0.1% Pt on alumina powder, 10 g each | P10K1001 | 10g |
| 0.5% Pt on alumina powder, 10 g each | P10K1005 | 10g |
| 1.0% Pt on alumina powder, 10 g each | P10K1010 | 10g |
| 5.0% Pt on alumina powder, 10 g each | P10K1050 | 10g |
| 10% Pt on alumina powder, 10 g each | P10K1100 | 10g |
| 20% Pt on alumina powder, 10 g each | P10K1200 | 10g |
| 0.1% Pd on alumina powder, 10 g each | P30K1001 | 10g |
| 0.5% Pd on alumina powder, 10 g each | P30K1005 | 10g |
| 1.0% Pd on alumina powder, 10 g each | P30K1010 | 10g |
| 5.0% Pd on alumina powder, 10 g each | P30K1050 | 10g |
| 10% Pd on alumina powder, 10 g each | P30K1100 | 10g |
| 20% Pd on alumina powder, 10 g each | P30K1200 | 10g |
| 5% Pt on Vulcan XC-72 | P10A050 | 1g/5g |
| 10% Pt on Vulcan XC-72 | P10A100 | 1g/5g |
| 20% Pt on Vulcan XC-72 | P10A200 | 1g/5g |
| 30% Pt on Vulcan XC-72 | P10A300 | 1g/5g |
| 40% Pt on Vulcan XC-72 | P10A400 | 1g/5g |
| 50% Pt on Vulcan XC-72 | P10A500 | 1g/5g |
| 60% Pt on Vulcan XC-72 | P10A600 | 1g/5g |
| 80% Pt on Vulcan XC-72 | P10A800 | 1g/5g |
| Pt Black, High surface area: 40-50 m2/g, Low density: 0.6-0.9 g/ml | P10V010 | 1g/5g |
| 20% Pt on Durable Carbon | P10D200 | 1g/5g |
| 20% Pt on Vulcan XC-72R | P10B200 | 1g/5g |
| 40% Pt on Vulcan XC-72R | P10B400 | 1g/5g |
| 60% Pt on Vulcan XC-72R | P10B600 | 1g/5g |
| 40% Pt on high surface area Ketjenblack | P10E400 | 1g/5g |
| 50% Pt on high surface area Ketjenblack, | P10E500 | 1g/5g |
| 60% Pt on high surface area Ketjenblack | P10E600 | 1g/5g |
| 70% Pt on high surface area Ketjenblack | P10E700 | 1g/5g |
| 5% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A050 | 1g/5g |
| 10% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A100 | 1g/5g |
| 20% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A200 | 1g/5g |
| 30% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A300 | 1g/5g |
| 40% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A400 | 1g/5g |
| 50% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A500 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72R | P12B600 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A600 | 1g/5g |
| 80% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A800 | 1g/5g |
| Pt-Ru Black (1:1 atomic ratio) | P12V010 | 1g/5g |
| Pt-Ru Black (2.5:1 atomic ratio) | P12V250 | 1g/5g |
| Pt-Ru-Ir Black (1:1:1 atomic ratio) | P124V010 | 1g/5g |
| 50% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E500 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E600 | 1g/5g |
| 75% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E750 | 1g/5g |
| 20% Pt-Pd (1:3 atomic ratio) on Vulcan XC-72 | P13A203 | 1g/5g |
| 20% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72 | P13A200 | 1g/5g |
| 20% Pt-Pd (3:1 atomic ratio) on Vulcan XC-72 | P13A230 | 1g/5g |
| 40% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72 | P13A400 | 1g/5g |
| Pt-Pd Black (1:1 atomic ratio) | P13V010 | 1g/5g |
| Pt-Rh Black (1:1 atomic ratio) | P15V010 | 1g/5g |
| 20% Pt-Ir (1:3 atomic ratio) on Vulcan XC-72 | P14A203 | 1g/5g |
| 20% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72 | P14A200 | 1g/5g |
| 20% Pt-Ir (3:1 atomic ratio) on Vulcan XC-72 | P14A230 | 1g/5g |
| 40% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72 | P14A400 | 1g/5g |
| Pt-Ir Black (1:1 atomic ratio) | P14V010 | 1g/5g |
| 20% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72 | P1AA230 | 1g/5g |
| 40% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72 | P1AA430 | 1g/5g |
| 20% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72 | P1BA200 | 1g/5g |
| 40% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72 | P1BA400 | 1g/5g |
| 40% Pt-Fe (3:1 atomic ratio) on Vulcan XC-72 | P1BA430 | 1g/5g |
| 20% Pt-Co (1:1 atomic ratio) on Vulcan XC-72 | P1CA200 | 1g/5g |
| 20% Pt-Co (3:1 atomic ratio) on Vulcan XC-72 | P1CA230 | 1g/5g |
| 40% Pt-Co (1:1 atomic ratio) on Vulcan XC-72 | P1CA400 | 1g/5g |
| 40% Pt-Co (3:1 atomic ratio) on Vulcan XC-72 | P1CA430 | 1g/5g |
| 60% Pt-Co (3:1 atomic ratio) on Ketjenblack | P1CE630 | 1g/5g |
| 20% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72 | P1DA200 | 1g/5g |
| 20% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72 | P1DA230 | 1g/5g |
| 40% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72 | P1DA400 | 1g/5g |
| 40% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72 | P1DA430 | 1g/5g |
| 60% Pt-Ni (3:1 atomic ratio) on Ketjenblack | P1DE630 | 1g/5g |
| 20% Pt-Cu (1:1 atomic ratio) on Vulcan XC-72 | P1EA200 | 1g/5g |
| 20% Pt-Cu (3:1 atomic ratio) on Vulcan XC-72 | P1EA230 | 1g/5g |
| 20% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72 | P1FA230 | 1g/5g |
| 40% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72 | P1FA430 | 1g/5g |
| 20% Pd-Ir (1:3 atomic ratio) on Vulcan XC-72 | P34A203 | 1g/5g |
| 20% Pd-Ir (1:1 atomic ratio) on Vulcan XC-72 | P34A200 | 1g/5g |
| 20% Pd-Ir (3:1 atomic ratio) on Vulcan XC-72 | P34A230 | 1g/5g |
| 20% Pd-Rh (1:1 atomic ratio) on Vulcan XC-72 | P35A200 | 1g/5g |
| 20% Pd-Rh (3:1 atomic ratio) on Vulcan XC-72 | P35A230 | 1g/5g |
| 20% Pd-Ni (1:1 atomic ratio) on Vulcan XC-72 | P3DA200 | 1g/5g |
| 40% Pd-Au (1:1 atomic ratio) on Ketjenblack | P13E400 | 1g/5g |
| 5% Pd on Vulcan XC-72 | P30A050 | 1g/5g |
| 10% Pd on Vulcan XC-72 | P30A100 | 1g/5g |
| 20% Pd on Vulcan XC-72 | P30A200 | 1g/5g |
| 40% Pd on Vulcan XC-72 | P30A400 | 1g/5g |
| 40% Pd on Ketjenblack | P30E400 | 1g/5g |
| 60% Pd on Vulcan XC-72 | P30A600 | 1g/5g |
| 80% Pd on Vulcan XC-72 | P30A800 | 1g/5g |
| Pd Black, High surface area 40~48 m2/g | P30V010 | 1g/5g |
| 20% Ru on Vulcan XC-72 | P20A200 | 1g/5g |
| 40% Ru on Vulcan XC-72, | P20A400 | 1g/5g |
| Ru Black, High surface area 38~48 m2/g | P20V010 | 1g/5g |
| RuO2 powder, Surface area 18-25 m2/g | P20V020 | 1g/5g |
| 5% Ir on Vulcan XC-72 | P40A050 | 1g/5g |
| 10% Ir on Vulcan XC-72 | P40A100 | 1g/5g |
| 20% Ir on Vulcan XC-72 | P40A200 | 1g/5g |
| 40% Ir on Vulcan XC-72 | P40A400 | 1g/5g |
| Ir Black, High Surface area, 55~65 m2/g, | P40V010 | 1g/5g |
| IrOx powder, conductive, SA:10-20 m2/g | P40V020 | 1g/5g |
| Ru-Ir Black (1:1 atomic ratio) | P24V010 | 1g/5g |
| 20% Rh on Vulcan XC-72 | P50A200 | 1g/5g |
| Rh Black, High surface area 40~50 m2/g | P50V010 | 1g/5g |
| 20% Au on Vulcan XC-72 (Au particle size: 4-8 nm) | P60N200 | 1g/5g |
| 20% Au on Vulcan XC-72 (Au particle size: ~25 nm) | P60A200 | 1g/5g |
| 30% Au on Vulcan XC-72 (Au particle size: 8 nm) | P60N300 | 1g/5g |
| 40% Au on Vulcan XC-72 (Au particle size: ~35 nm) | P60A400 | 1g/5g |
| 40% Au on Ketjenblack (Au particle size: 4 nm) | P60E400 | 1g/5g |
| 60% Au on Vulcan XC-72 (Au particle size: ~45 nm) | P60A600 | 1g/5g |
| 5% Fe on Vulcan XC-72 | T10A050 | 1g/5g |
| 10% Fe on Vulcan XC-72 | T10A100 | 1g/5g |
| 20% Fe on Vulcan XC-72 | T10A200 | 1g/5g |
| 1% Co on Vulcan XC-72 | T20A010 | 1g/5g |
| 5% Co on Vulcan XC-72 | T20A050 | 1g/5g |
| 10% Co on Vulcan XC-72 | T20A100 | 1g/5g |
| 20% Co on Vulcan XC-72 | T20A200 | 1g/5g |
| 1% Ni on Vulcan XC-72 | T30A010 | 1g/5g |
| 5% Ni on Vulcan XC-72 | T30A050 | 1g/5g |
| 10% Ni on Vulcan XC-72 | T30A100 | 1g/5g |
| 20% Ni on Vulcan XC-72 | T30A200 | 1g/5g |
| 40% Ni on Vulcan XC-72 | T30A400 | 1g/5g |
| 1% Cu on Vulcan XC-72 | T40A010 | 1g/5g |
| 5% Cu on Vulcan XC-72 | T40A050 | 1g/5g |
| 10% Cu on Vulcan XC-72 | T40A100 | 1g/5g |
| 20% Cu on Vulcan XC-72 | T40A200 | 1g/5g |
| 40% Cu on Vulcan XC-72 | T40A400 | 1g/5g |
| 60% Cu on Vulcan XC-72 | T40A600 | 1g/5g |
| 20% Ag on Vulcan XC-72 | P70A200 | 1g/5g |
| 40% Ag on Vulcan XC-72 | P70A400 | 1g/5g |
| 60% Ag on Vulcan XC-72 | P70A600 | 1g/5g |
| 80% Ag on Vulcan XC-72 | P70A800 | 1g/5g |
| Platinum (II) acetylacetonate, 5 g each | P10H110 | 5g |
| (1,5-Cyclooctadiene)dimethylplatinum(II), 1 g each | P10H120 | 1g |
| Dichloro(1,5-cyclooctadiene)platinum(II), 5 g each | P10H130 | 5g |
| Diphenyl(1,5-cyclooctadiene)platinum(II), 5 g each | P10H140 | 5g |
| Trimethylbenzylammoniumhexachloroplatinate (IV), 1 g each | P10H150 | 1g |
| Palladium(II) acetylacetonate, 5 g each | P30H110 | 5g |
| Dichloro(1,5-cyclooctadiene)palladium(II), 5 g each | P30H120 | 5g |
| Hermann's Catalyst, 5 g each | P30H130 | 5g |
| 1,1'-Bis(di-tert-butylphosphino)ferrocene palladium dichloride, 1 g each | P30H140 | 1g |
| Bis(dibenzylideneacetone)palladium(0), 5 g each | P30H150 | 5g |
| Palladium(0) tetrakis(triphenylphosphine), 5 g each | P30H160 | 5g |
| Ruthenium(III) acetylacetonate, 5 g each | P20H110 | 5g |
| Dichloro(1,5-cyclooctadiene)ruthenium(II), polymer, 5 g each | P20H120 | 5g |
| Bis(cyclopentadienyl)ruthenium, 5 g each | P20H130 | 5g |
| Irridium(III) acetylacetonate, 5 g each | P40H110 | 5g |
| Chloro(1,5-cyclooctadiene)iridium(I) dimer, 5 g each | P40H120 | 5g |
| Rhodium(III) acetylacetonate, 5 g each | P50H110 | 5g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 1 g each | P50H120 | 1g |
| Chloro(triphenylphosphine)gold(I), 5 g each | newitem3 | 5g |
| Bromo(triphenylphosphine)gold(I), 5 g each | P60H110 | 5g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g | P50-002 | 1g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g | P50-002 | 1g |
| Doyledirhodium catalyst-Rh2(5R-MPPIM)4, 1 g | P50-001 | 1g |
| Doyledirhodium catalyst-Rh2(5S-MPPIM)4, 1 g | P50-003 | 1g |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18327026838
传真:15172469628
邮箱:sales@amyjet.com
0.3271